Related Experiment Video
Updated: Nov 11, 2025

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
The MSP-RON pathway regulates liver fibrosis through transforming growth factor beta-dependent epithelial-mesenchymal
Tianhao Weng1, Dong Yan1, Danrong Shi1
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Background:
Liver fibrosis is pathologically important in the liver cirrhosis progression. The epithelial-mesenchymal transition (EMT) is crucial for organ fibrosis. Macrophage-stimulating protein (MSP) and its receptor tyrosine kinase, RON, promote cellular EMT. However, their role in liver fibrosis is unclear. Here, we clarify the biological profile, potential mechanisms and therapeutic targets of the MSP-RON pathway in liver fibrosis.
Materials And Methods:
Macrophage-stimulating protein expression and its correlation with clinicopathological characteristics of cirrhosis were evaluated in 57 clinical cases and a control group. The effect of MSP-RON pathway in liver fibrosis was determined in vitro and in vivo. The therapeutic effects of MSP or RON inhibition on liver fibrosis were evaluated in a mouse liver fibrosis model.
Results:
Macrophage-stimulating protein is upregulated in liver cirrhosis, which was associated with poor patient prognosis. The MSP-RON pathway promoted hepatocytes EMT. MSP-RON-induced EMT depends on the transforming growth factor beta (TGF-β) pathway and is regulated by TGF-β inhibitors. In animal models, an MSP blocking antibody and a small molecule inhibitor of RON, BMS-777607, both inhibited liver fibrosis progression.
Conclusion:
Our study revealed that MSP is an important biomarker in liver cirrhosis progression and can be used to prognose patients. The MSP-RON pathway promotes the EMT of hepatocytes and the progress of fibrosis via a TGF-β related pathway. Consequently, we identified a new treatment strategy for liver cirrhosis through targeted inhibition of MSP/RON. This research increases the understanding of EMT-modulated liver fibrosis and provides new insights into biomarkers and therapeutic targets of liver fibrosis.
Insights
Macrophage-stimulating protein (MSP) is elevated in liver cirrhosis and drives fibrosis by promoting hepatocyte epithelial-mesenchymal transition (EMT). Targeting the MSP-RON pathway offers a novel therapeutic strategy for liver cirrhosis.
Area of Science:
- Hepatology
- Molecular Biology
- Fibrosis Research
Background:
- Liver fibrosis is a critical step in cirrhosis development.
- Epithelial-mesenchymal transition (EMT) is a key process in organ fibrosis.
- The role of the Macrophage-stimulating protein (MSP)-RON pathway in liver fibrosis was previously unclear.
Purpose of the Study:
- To elucidate the biological profile and mechanisms of the MSP-RON pathway in liver fibrosis.
- To identify the MSP-RON pathway as a potential therapeutic target for liver cirrhosis.
Main Methods:
- Evaluated MSP expression in 57 cirrhosis cases and controls.
- Assessed MSP-RON pathway effects on liver fibrosis in vitro and in vivo.
- Tested therapeutic efficacy of MSP or RON inhibition in a mouse liver fibrosis model.
Main Results:
- MSP was upregulated in liver cirrhosis, correlating with poor prognosis.
- The MSP-RON pathway promoted hepatocyte EMT, dependent on the TGF-β pathway.
- MSP blocking antibody and RON inhibitor BMS-777607 reduced liver fibrosis in mice.
Conclusions:
- MSP serves as a prognostic biomarker for liver cirrhosis.
- The MSP-RON pathway exacerbates liver fibrosis via TGF-β-dependent EMT.
- Targeted inhibition of MSP/RON presents a new therapeutic avenue for liver cirrhosis.
Related Concept Videos
TGF - β Signaling Pathway
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

